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Abstract
Introduction: Although the prevalence of arthritis dramatically increases with age, the great majority of preclinical
studies concerning the mechanisms that drive arthritic joint pain have been performed in young animals. One
mechanism hypothesized to contribute to arthritic pain is ectopic nerve sprouting; however, neuroplasticity is
generally thought to be greater in young versus old nerves. Here we explore whether sensory and sympathetic
nerve fibers can undergo a significant ectopic nerve remodeling in the painful arthritic knee joint of geriatric mice.
Methods: Vehicle (saline) or complete Freund’s adjuvant (CFA) was injected into the knee joint of 27- to 29-
month-old female mice. Pain behaviors, macrophage infiltration, neovascularization, and the sprouting of sensory
and sympathetic nerve fibers were then assessed 28 days later, when significant knee-joint pain was present. Knee
joints were processed for immunohistochemistry by using antibodies raised against CD68 (monocytes/
macrophages), PECAM (endothelial cells), calcitonin gene-related peptide (CGRP; sensory nerve fibers),
neurofilament 200 kDa (NF200; sensory nerve fibers), tyrosine hydroxylase (TH; sympathetic nerve fibers), and
growth-associated protein 43 (GAP43; nerve fibers undergoing sprouting).
Results: At 4 weeks after initial injection, CFA-injected mice displayed robust pain-related behaviors (which
included flinching, guarding, impaired limb use, and reduced weight bearing), whereas animals injected with
vehicle alone displayed no significant pain-related behaviors. Similarly, in the CFA-injected knee joint, but not in
the vehicle-injected knee joint, a remarkable increase was noted in the number of CD68+ macrophages, density of
PECAM+ blood vessels, and density and formation of neuroma-like structures by CGRP+, NF200+, and TH+ nerve
fibers in the synovium and periosteum.
Conclusions: Sensory and sympathetic nerve fibers that innervate the aged knee joint clearly maintain the
capacity for robust nerve sprouting and formation of neuroma-like structures after inflammation/injury.
Understanding the factors that drive this neuroplasticity, whether this pathologic reorganization of nerve fibers
contributes to chronic joint pain, and how the phenotype of sensory and sympathetic nerves changes with age
may provide pharmacologic insight and targets for better controlling aging-related joint pain.
Introduction
The prevalence of arthritis generally increases with age
and is frequently accompanied by significant joint pain
[1-5]. In individuals with arthritis (for example, rheuma-
toid arthritis (RA), osteoarthritis (OA)), joint pain gener-
ally decreases the functional status and quality of life, as
it is strongly associated with physical disability,
decreased mobility, depression, sleep disturbances, and
increased health care costs [1,2,6-9]. Currently, we know
relatively little about the mechanisms that drive arthritic
joint pain. This is reflected in the fact that we have
remarkably few effective analgesic therapies for treating
joint pain that are not accompanied by significant
unwanted side effects [1,10-12]. As the life expectancy
of humans continues to increase in both the developing
and developed world [13,14], age-related arthritic joint
pain is expected to exact an ever-increasing toll on aged
individuals and society.
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Arthritic joint pain most frequently occurs with move-
ment and/or loading of the affected joint but can also
be present at rest [15,16]. Movement or loading-induced
joint pain is usually described as sharp and/or stabbing,
whereas arthritic joint pain at rest is usually described
as burning and/or throbbing, with occasional bouts of
stabbing pain [15-17]. Currently, it is believed that spon-
taneous arthritic pain (joint pain at rest) and movement-
evoked pain are largely driven by joint injury and/or
inflammation, which induces both a peripheral sensitiza-
tion (an increase of sensitivity of nociceptive primary
afferent neurons) and central sensitization (hyperexcit-
ability of neurons conveying nociceptive information in
the central nervous system (CNS)) (see [1,18-20] for
review). However, it remains largely unknown why a
relatively poor correlation exists in OA between the
radiologic signs of arthritis (for example, joint-space
narrowing, erosive changes) and the severity of arthritic
pain [1,2,21] as well as the specific mechanisms that
drive spontaneous versus movement-evoked arthritic
joint pain in OA. This dissociation between pain and
disease progression is also observed in RA, as even
therapies such as tumor necrosis factor-a inhibitors that
can be quite effective at decreasing the severity of joint
inflammation/swelling in RA are generally much less
efficacious at attenuating RA pain [22].
One potential mechanism that may explain the disso-
ciation between disease progression and pain in arthritis
is that an active and ectopic sprouting of sensory and
sympathetic nerve fibers plays a role in driving pain due
to arthritis. For example, a previous study performed in
young rats suggested that after injection of complete
Freund adjuvant (CFA) into the temporomandibular
joint of rats, significant sprouting of sensory nerve fibers
occurred in the painful arthritic joint [23]. However, as
aging is generally associated with a decline and dete-
rioration of the ability of tissues to grow (with the
exception of cancers) [24-27], it is not clear whether
sensory or sympathetic neurons in aged animals retain
the ability to undergo exuberant ectopic sprouting, and
if so, whether sprouting is relevant to understanding the
mechanisms that drive pain in the aged arthritic joint.
In this study, we examined the ability of sensory and
sympathetic nerve fibers to undergo ectopic sprouting.
The model used here was generated by unilaterally
injecting CFA into the articular space of the knee joint
of geriatric (27- to 29-month-old) female mice. With
this model, we demonstrate that even in the arthritic
knee joint of these geriatric mice, robust sprouting and
formation of neuroma-like structures by both sensory
and sympathetic nerve fibers was observed in all CFA-
injected animals and in none of the vehicle-injected
mice. These newly sprouted sensory and sympathetic
nerve fibers were not only present in a higher density
per unit area than was ever found in the normal aged
joint, but were also found in areas of the joint that are
normally poorly or not innervated.
Materials and methods
Animals
Experiments were performed on a total of 12 geriatric
female B6/C3H mice (a generous gift from Rinat-Pfizer,
San Francisco, CA, USA). Mice were received at our
animal care facilities 2 months before experiments were
performed. At the time of initiation of the experiments,
mice were 27 to 29 months old. The mice were housed
in accordance with the National Institutes of Health
guidelines under specific pathogen-free conditions in
autoclaved cages maintained at 22°C with a 12-hour
alternating light-and-dark cycle and were given auto-
claved food and water ad libitum. The Institutional Ani-
mal Care and Use Committee at the Minneapolis VA
Medical Center approved all procedures.
Complete Freund’s adjuvant injection
A modified version of a previously validated model of
arthritic inflammation of the knee joint [28] was pro-
duced by performing four intraarticular injections of
complete Freund’s adjuvant (CFA) dissolved in saline or
saline alone (vehicle) at days 0, 7, 14, and 21 unilater-
allly into the left-knee joint. At days 0 and 7, mice
received 5 μl of CFA (1 μg/μl), and at days 14 and 21,
mice received 10 μl of CFA (1 μg/μl). Mice treated with
vehicle received the same injection volume of saline. In
brief, mice were anesthetized by using 2% to 3% isoflur-
ane mixed with air. An injection of CFA was given by
using a 30-gauge, 1/2-inch needle that was fitted with
cannulation tubing such that only 2.5 mm of the needle
was allowed to puncture the joint. CFA or saline (vehi-
cle) was injected through the patellar ligament into the
articular space, by using the femoral condyles as a guide.
Currently, there is no well-accepted rat or mouse
model of osteoarthritis (OA) simultaneously induces
robust joint destruction and pain similar to that
observed in humans with painful OA. One rodent
model that has been used as a surrogate in terms of OA
pain is CFA injection into the knee joint. As previous
results from this model [29] were used to guide the
human trials of anti-NGF (which proved highly effica-
cious in reducing human OA pain [30]), we chose to
use this model to examine potential nerve sprouting in
the painful inflamed knee joint. However, it is important
to note that although pain behaviors were present at 4
weeks after injection, no signs were seen of significant
cartilage destruction and osteophyte formation, as evalu-
ated with histologic analysis in the knee joint. This
result contrasts with the pathology reported in preclini-
cal models of OA, including intraarticular injection of
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monoiodoacetate or surgical destabilization of the joint.
Additionally, in our hands, CFA injections caused infil-
tration of CD68+ monocytes/macrophages into the syno-
vial membrane as well as tissues outside the joint,
including tendons, ligaments, and surrounding muscle
(data not shown). Taken together, these results suggest
that the present model involves an inflammation in the
synovium as well as the tendons and ligaments of the
CFA-injected knee joint without signs of cartilage
destruction.
Behavioral measures of arthritic joint pain
Behavioral measures of arthritic joint pain included
spontaneous pain (guarding and flinching), stimulus-
evoked pain (limb use), and the ability of the animal to
place weight on the arthritic limb versus the nonar-
thritic limb while ambulatory (dynamic weight bearing).
In brief, the number of hindpaw flinches and time spent
guarding were recorded as measures of spontaneous
pain, as these measures mirror patients in a clinical set-
ting with arthritis who have spontaneous pain (joint
pain at rest) [15,31]. The number of spontaneous
flinches and time spent guarding, representative of
spontaneous nocifensive behavior, were recorded during
a 2-minute observation period, as previously described
[32-38]. Flinches were defined as the number of times
the animal raised its hindpaw and guarding as the
amount of time animals held the hindpaw aloft while
not ambulatory. Based on our previous experience eval-
uating spontaneous pain-related behaviors in mice, three
or more flinches and two or more seconds spent guard-
ing during a 2-minute interval suggest the presence of
pain-related behaviors.
Normal limb use during spontaneous ambulation in
an open field was used as an indicator of stimulus-
evoked pain and was scored on a scale of 5 to 0, as pre-
viously reported [34,38], where (5) is normal use, (4) is
partial limp, but not pronounced, (3) is pronounced
limp, (2) is limp and guarding behavior, (1) is partial
nonuse of limb in locomotor activity, and (0) is com-
plete lack of limb use. One trial of approximately 1 to 2
minutes was performed per test period. Evaluation of
normal limb use during ambulation was performed to
reflect the clinical condition when patients with arthritis
have pain after movement of the joint [15,31].
Behavioral measures of arthritic joint pain included
spontaneous pain (guarding and flinching) and stimulus-
evoked pain (limb use) were performed at day 28 after
CFA initial injection, whereas dynamic weight bearing
was determined at day 23 after initial injection. Not
enough time was available in a single day to perform all
four behaviors.
Dynamic weight-bearing analysis of the arthritic limb
was performed on days 0 and 23 after initial
intraarticular CFA injection with the use of a Dynamic
Weight Bearing device (EB Instruments, Pinellas Park,
Florida, USA). Similar pedobarographic analysis is used
clinically to determine the weight bearing of patients
with arthritic knee joints [39]. The mouse was allowed
to move freely on the electronic sensor pad within the
apparatus for 5 minutes, and the sensor-captured
weight-bearing information was transmitted live to a
computer. By using a synchronized video recording of
the test and the scaled map of the detected zones, each
presumed paw detection was validated by an observer
and identified as a left or right and fore- or hindpaw.
Dynamic weight bearing on the affected (left) hindlimb
was calculated and reported as a percentage of total
weight bearing on both hindlimbs.
Immunohistochemistry
At day 28 after initial CFA injection, mice were deeply
anesthetized with carbon dioxide asphyxiation, delivered
by using a compressed gas cylinder, and perfused intra-
cardially with 20 ml of 0.1 M phosphate-buffered saline
(PBS; pH 7.4 at 4°C) followed by 30 ml of 4% formalde-
hyde/12.5% picric acid solution in 0.1 M PBS (pH 6.9 at
4°C). Ipsilateral and contralateral knee joints were har-
vested after perfusion and postfixed for at least 12 hours
in the same perfusion fixative. The process of postfixing,
decalcification, and sectioning of the bones/joints was
performed as previously described [40,41].
To qualitatively assess the changes in the density and
morphology of sensory nerve fibers that innervate the
knee joint, the macrophage infiltration, and neovascular-
ization of the synovium, 20 μm-thick frozen sections of
the bone/joint were processed according to our pre-
viously published procedures [35,40,41]. Frozen bone/
knee-joint sections were incubated with an antibody
against calcitonin gene-related peptide (CGRP, polyclo-
nal rabbit anti-rat CGRP; 1:10,000; Sigma Chemical Co.
St Louis, MO, USA; catalog no. C8198) to label primary
afferent sensory nerve fibers, an antibody against neuro-
filament 200 kDa (NF200, chicken anti-neurofilament
200 kDa; NF200, 1:5,000; Neuromics, Edina, MN, USA;
catalog no. CH22104) to label myelinated primary affer-
ent sensory nerve fibers. Sympathetic nerve fibers were
labeled with an antibody against tyrosine hydroxylase
(TH, polyclonal rabbit anti-rat TH, 1:1,000; Chemicon,
Billerica, MA, USA; catalog no. AB152). Sprouted nerve
fibers were labeled with an antibody against growth-
associated protein-43 (GAP-43, rabbit anti-GAP43,
1:1,000; Millipore, Billerica, MA, USA; catalog no.
AB5220). Blood vessels were labeled with an antibody
against platelet endothelial cell adhesion molecule (rat
anti-mouse PECAM, 1:500, BD PharMingen, San Jose,
CA, USA; catalog no. 550274). Monocytes/macrophages
were indentified with an antibody against a myeloid
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glycoprotein (rat anti-mouse CD68; 1:2,000, AbD Sero-
tec, Raleigh, NC, USA; catalog no. MCA1957). Addition-
ally, four to five sequential frozen bone sections were
cut at 10 μm thick and were stained with safranin-O/
fast green to visualize gross pathologic changes in carti-
lage and bone induced by CFA.
Quantification of nerve fiber density, sprouting,
macrophage infiltration and neovascularization
Approximately 30 separate, 20-μm-thick frozen sections
were obtained from the knee joint of each mouse. Three
confocal images (Olympus America Inc, Center Valley,
PA, USA; software v. 5.0) from different sections sepa-
rated by at least 100 μm were obtained for each marker.
Sections were initially scanned at low magnification
(×100) to identify areas with the highest capillary or ner-
vefiber density in the synovium. These areas in the
synovium were defined as “hot spots.” One image per
section was acquired within the medial synovial hot
spot. Whereas nerve fibers, blood vessels, and macro-
phages were observed throughout the inflamed syno-
vium, neovascularization and nerve sprouting was
consistently present in the synovium adjacent to the
meniscus, therefore, most of the hot spots were found
and quantified in this area. In the knee sections from
naïve and sham mice, no evidence of “hot spots” was
noted in terms of significant changes in the morphology
or density of nerve fibers and blood vessels.
The volume of CFA-inflamed synovium analyzed was
315 μm (length), 315 μm (width), and 20 μm (depth).
The Z-stacked images were analyzed with Image-Pro
Plus v. 6.0 (Media Cybernetics, Bethesda, MD, USA),
and nerve fibers and blood vessels were manually traced
to determine their respective lengths. To determine
whether a structure in the image was a nerve-fiber pro-
file, simultaneous observations of the image on a high-
resolution computer monitor and the section viewed in
the microscope were performed. The fine focus of the
microscope was used to follow the fibers across the
entire thickness of the knee section. Structures were
considered nerve profiles only if their signal was at least
3 times greater than background signal, if their length
was > 20 μm, and if they displayed the presence of dila-
tations (varicosities). Small dot-like structures were not
counted, even though these structures likely represented
cut fibers. Nerve sprouting or neovascularization was
reported as density of nerve fibers or blood vessels per
volume of synovium (mm/mm3) [40]. CD68+ macro-
phages were quantified in each layer of the inflamed
synovium from z-series images (×400 magnification) of
each field of view by using Imaris Pro Software v. 6.0
(Bitplane AG, South Windsor, CT, USA). Only CD68+
cells that displayed visible nuclei, as determined by
counterstaining with DAPI, were counted. Only CD68+
macrophages/monocytes located in the normal or
inflamed synovium were quantified. Macrophages/
monocytes were defined as CD68+ profiles that were
distant from any bone surface, whereas osteoclasts were
defined as CD68+ profiles that were directly apposed to
mineralized bone [42,43].
Data from at least three slices per knee joint were
recorded and averaged. The total number of CD68+
macrophages in the synovium was reported. Total
volume of the synovium (naïve and inflamed) was calcu-
lated by tracing the area of the synovium and multiply-
ing this area by the thickness of the section (20 μm).
Density of nerve fibers, PECAM+ blood vessels and
CD68+ monocytes/macrophages in the femoral perios-
teum were calculated within the distal metaphysic, as sig-
nificant neural remodeling was observed in this region.
The area evaluated in frozen sections was within a 1.0-
mm-long region, which started 0.5 mm below the distal
femoral growth plate. For frozen sections, the average
volume of periosteum analyzed was 315 μm (length), 50
μm (width), and 20 μm (depth). The confocal images
were viewed on a high-resolution monitor, and the length
of nerve fibers was determined by manually tracing the
nerve or blood vessel profile by using Image Pro Plus v.
6.0 image analysis software (Media Cybernetics,
Bethesda, MD, USA). Nerve sprouting or neovasculariza-
tion was reported as density of nerve fibers or blood ves-
sels per volume of periosteum (mm/mm3). Data from at
least three slices per knee joint were recorded and aver-
aged. CD68+ macrophages were quantified in both layers
of the periosteum from z-series images of each field by
using Imaris Pro-Software v. 6.0 (Bitplane AG, South
Windsor, CT, USA). The density of CD68+ macrophages
in the periosteum was reported as number of CD68+
macrophages per volume of periosteum.
To determine whether changes were present in the
density of nerve fibers or the formation of neuroma-like
structures, frozen sections were examined at low magni-
fication with an epifluorescent microscope. Areas that
were examined included the lower half of the femur and
the upper half of the tibia and included the mineralized
bone, bone marrow, cartilaginous knee joint, synovium,
periosteum, and knee-joint ligaments. In general, areas
that contained sprouting of nerve fibers and neuroma-
like structures were remarkably different from nerve
fibers in the normal bone and joint in terms of mor-
phology and density. For example, a neuroma-like struc-
ture was defined as a disordered mass of axons (CGRP+,
NF200+) that has an interlacing and/or whirling mor-
phology, a size that is at least 10 μm thick by 70 μm
long (> 10 individual axons) [44-46], and that we have
never observed in any bone or joint compartment,
including the synovium or periosteum of normal joint
or bone [41,47-49].
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Statistics
A t test was used to compare the behavioral measures of
spontaneous pain (guarding and flinching) and dynamic
weight bearing. The Mann-Whitney Rank Sum Test was
used to compare the stimulus-evoked pain (limb use).
One-way ANOVA followed by the Dunnett post hoc test
was used for the immunohistochemical measures
between the experimental groups. Significance level was
set at P < 0.05. In all cases, the investigator responsible
for behavioral testing, plotting, measuring, and counting
was blind to the experimental situation of each animal.
Results
CFA injection into the knee joint of geriatric mice
produces significant pain-related behaviors
Pain-related behaviors were evaluated in CFA-injected
animals as compared with saline-treated animals.
Assessment of arthritic joint pain-related behaviors,
including spontaneous guarding and flinching, and limb-
use analysis of the hindlimb was performed on day 28
after initial intraarticular CFA injection, and dynamic
weight-bearing analysis was performed on day 23 after
initial intraarticular CFA injection (Figure 1). At day 28
post-injection, CFA-treated mice exhibited a greater
time spent guarding, and number of flinches as com-
pared to those observed in vehicle-treated mice (Figure
1). Additionally, the evaluation of ambulatory pain
revealed that the mean score of limb use was reduced
from a 4.3 ± 0.1 in vehicle-treated mice to 2.7 ± 0.11 in
CFA-treated mice at day 28 after cell injection. Similarly,
CFA-induced arthritis resulted in a significant reduction
in dynamic weight bearing of the CFA-injected hin-
dlimb, as compared with the vehicle-treated hindlimb
(Figure 1).
CFA injection into the knee joint of geriatric mice
produces joint edema, infiltration of macrophages, and
aberrant neovascularization in the synovium
Repeated injections of CFA resulted in significant edema
within the knee joint at day 28 after initial injection. In
all CFA-injected mice, the inflammation was restricted
to the ipsilateral joint with no evidence of inflammation
present in the contralateral hindlimb.
CFA-induced changes in structures of the knee joint,
including bone, synovium, and periosteum were exam-
ined with histology (safranin-O/fast green staining) and
immunonohistochemistry. At day 28 after initial injec-
tion, the repeated intraarticular injection of vehicle did
not induce a visible inflammatory response in the syno-
vium (Figure 2B) or major changes in the structure of
articular cartilage (femur and tibia). The knee sections
from vehicle-treated mice and mice without injection
(naïve) were similar in appearance. In contrast, repeated
injections of CFA into the knee induced an extensive
inflammation in the synovial membrane and thickening
of the joint capsule (Figure 2A, C). Repeated CFA injec-
tions caused the infiltration of many CD68+ monocytes/
macrophages into the synovial membrane (Figure 2E)
and tissues outside the joint (periarticular inflammation)
including tendons, ligaments, and surrounding muscle
(data not shown). Knee sections stained with antibody
that recognizes endothelial cells found in blood vessels
(PECAM), showed few small blood vessels in the syno-
vial membrane (Figure 2F) of vehicle-treated mice. In
contrast, CFA injection induced an increase in the num-
ber of PECAM+ blood vessels, which were different
from those that vascularize normal synovium, as they
were thicker and exhibited disorganized, nonlinear mor-
phology (Figure 2G).
Quantitative image analysis revealed an increase in the
volume of the synovial membrane during arthritis from
0.0044 ± 0.0003 mm3 in vehicle-treated knees to 0.1454
± 0.0186 mm3 on Day 28 in CFA-treated knees (Figure
3A). A significant increase in the density of PECAM+
blood vessels was present in CFA-treated knees as com-
pared with vehicle-treated or naïve knees (Figure 3B).
The CD68+ monocyte/macrophage density in the syno-
vium of CFA-treated knees was not significantly differ-
ent as compared with the synovium from vehicle-treated
knees (Figure 3C). When the total number of CD68+
monocytes/macrophages in the synovium was calculated
as the product of cell density and synovial volume, the
normalized total cell number in the synovium was sig-
nificantly greater in CFA-treated mice (11 007 ± 1,125
CD68+ profiles) as compared with vehicle-treated (365 ±
63 CD68+ profiles) or naïve mice (301 ± 42 CD68+
profiles).
CFA injection into the knee joint of geriatric mice
produces sprouting and formation of neuroma-like
structures by sensory and sympathetic nerve fibers in the
synovium and periosteum
CGRP+ (sensory, Figure 4B), NF200+ (sensory, Figure
4D), TH+ (sympathetic), and GAP43+ (nerve fibers
undergoing sprouting; Figure 4I) nerve fibers were evi-
dent only at low levels in the synovial-meniscal interface
from vehicle-treated knee sections (Figure 4B, D, F, H).
In contrast, 28 days after the initial CFA injection, a
robust sprouting of CGRP+, NF200+, TH+, and GAP43+
nerve fibers was observed within the synovium of the
inflamed joint (Figure 4C, E). These newly sprouted
nerve fibers are found in higher density (Figure 5) and
have a highly disorganized appearance as compared with
the primarily linear morphology of these nerve fibers in
the synovium of vehicle-treated or naïve mice. Whereas
100% of CFA-injected mice showed significant sprouting
of CGRP+, NF200+, GAP43+, and TH+ nerve fibers, five
of six mice had two to three neuroma-like structures in
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the synovium (Figure 4G). Only one of six mice dis-
played a large neuroma (approximate thickness of 50
μm). These neuroma-like structures appear as a disor-
dered mass of blind-ending axons that have an interla-
cing or whirling morphology and are never observed in
vehicle-treated mice (Figure 4F).
To determine whether the nerve sprouting induced by
the arthritis was present in other knee-joint compart-
ments, we qualitatively examined cartilage, synovium,
cortical bone, trabecular bone, marrow space, ligaments,
and periosteum. Sensory and sympathetic nerve fibers
were present in these compartments, as previously
described [48-54], however, a noticeable change in the
density of sensory and sympathetic nerve fibers and/or
neuroma formation was observed only in the synovium
and periosteum of inflamed knee joints. Confocal micro-
graphs of metaphyseal periosteum preparations from
vehicle-treated mice revealed that CGRP+ (Figure 6B)
and NF200+ (Figure 6D) nerve fibers normally have a lin-
ear and bifurcating pattern. In contrast, periosteal pre-
parations from CFA-treated mice displayed an aberrant
and disorganized morphology of CGRP+ (Figure 6C),
NF200+ (Figure 6E) sensory nerve fibers. The majority of
TH+ sympathetic fibers in the periosteum of vehicle-trea-
ted mice possessed a unique “corkscrew” morphology
that appeared to wrap around small blood vessels in the
periosteum (Figure 6F). In contrast, in the periosteum of
CFA-treated mice TH+ nerve fibers displayed a highly
pathologic and disorganized pattern of innervation as
well as appearing to wrap large blood vessels in a tight
corkscrew-like fashion (Figure 6G). Additionally, five of
six mice treated with CFA had two to three neuroma-like
structures in the periosteum (Figure 6I).
Quantitative analysis of the density of nerve fibers
(expressed as length of nerve fibers/mm3 of femoral

























































































































































Figure 1 A complete Freund’s adjuvant model of inflammatory arthritis induces significant and long-term pain behaviors. The
spontaneous time spent guarding (A), and the number of spontaneous flinches (C) in CFA-treated mice were significantly greater than those in
vehicle-treated mice at 28 days after initial CFA injection. In addition, limb use (B) and dynamic weight bearing of the ipsilateral hindlimb (D)
declined significantly after the initial CFA injection and continued to decline through the 24-day experimental period. Bars represent the mean
of at least five mice ± SEM. *P < 0.05 versus mice that received intraarticular injections of saline.
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resulted in a significant increase in the density of CGRP
+ fibers as compared with mice treated with vehicle
(3,314.9 ± 377 versus 2,085 ± 380 mm/mm3; P < 0.05).
Likewise, the density of NF200+ sensory nerve fibers in
the femoral periosteum was significantly increased in
CFA-treated mice as compared with vehicle-treated
(3,944 ± 1,176 versus 1,144 ± 160 mm/mm3; P < 0.05).
Similarly, the density of postganglionic TH+ sympathetic
nerve fibers increased significantly in the femoral perios-
teum of mice treated with CFA as compared with
vehicle-treated mice (3,392 ± 291 versus 1,020 ± 64
mm/mm3; P < 0.05). Finally, the density of nerve fibers
undergoing sprouting (GAP43+) also increased signifi-
cantly in the femoral periosteum of mice that received
intraarticular injections of CFA as compared with mice
injected with vehicle (4,677 ± 805 versus 1,596 ± 261
mm/mm3; P < 0.05). The density of nerve fibers in the
periosteum of vehicle-treated mice was not significantly
different when compared with femoral periosteum of












Figure 2 CFA injection into the geriatric knee joint induces synovial inflammation, macrophage infiltration, and neovascularization. (A)
Schematic of the frontal view of a cross-sectioned mouse knee joint, indicating the location of the major cellular and structural changes
occurring in the arthritic knee joint. (B-G) Longitudinal cross sections (10 μm thick) of the knee joint stained with safranin-O/fast green display
the histopathologic changes in the synovium and capsule 28 days after initial injection of complete Freund’s adjuvant (CFA). In the vehicle-
injected mice, the synovium is very thin and relatively intact (B), whereas in CFA-injected mice, an extensive inflammation in the synovial
membrane and thickening of the joint capsule are found (C). The outlined boxes in B and C illustrate the region from which the subsequent
confocal images were obtained. Representative confocal images of CD68+ macrophages (D, E, red/orange), DAPI-labeled nuclei (blue), and a
vascular endothelial marker, PECAM+ (F, G, red) in vehicle-injected (D, F) and CFA-injected (E, G) mouse knee-joint sections (20 μm-thick).
Injections of CFA induce a significant infiltration of CD68+ macrophages into the synovium (E), as compared with vehicle-treated mice (D). In
vehicle-injected mice, a low-level vascularization by PECAM+ vessels is observed in the synovial space of the knee joint (F). In contrast, in CFA-
treated knee joints, a significant number of PECAM+ vessels have developed and have an enlarged and disorganized morphology (G), as
compared with vehicle-treated mice.
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Discussion
Age, arthritis, and joint pain
Although chronic joint pain can be caused by a diverse
group of injuries and disorders, what most forms of
arthritis have in common is that the prevalence
increases with age and is frequently accompanied by sig-
nificant pain and impairment of physical function
[1-6,55]. Unfortunately, management of age-related ske-
letal pain can be difficult, as current therapies are often
not fully effective and have a high incidence of dose-lim-
iting side effects [10-12]. Thus, the major therapies used
to treat arthritic joint pain are nonsteroidal antiinflam-
matory drugs (NSAIDs) and opioids, which have
remained virtually unchanged for decades [11,12].
Disease progression and joint pain
Currently, our understanding of what drives arthritic
joint pain is that joint injury, inflammation, and/or dete-
rioration of the joint causes an increased responsiveness
of the joint nociceptors (peripheral sensitization) and of
the nociceptive neurons of the CNS (central sensitiza-
tion) (see [1,18,19] for review). It has been reported that
as joint and adjacent bone are injured because of
inflammation, nerves that innervate the bone are first
activated and sensitized by factors such as bradykinin,
prostaglandin E2, prostaglandin I2, serotonin, substance
P, galanin, neuropeptide Y, and nociceptin, which are
released by stromal/inflammatory/immune cells in the
injured joint (see [18,19] for review). As the joint con-
tinues to deteriorate, these “sensitized” nerve fibers then
become activated when noxious or nonnoxious mechan-
ical stimuli are applied to the joint (see [1,18-20] for
review). As the cartilage deteriorates to the point at
which it is no longer intact, bone-on-bone interactions
can occur, which may induce direct mechanical stimula-
tion of these sensitized nerve fibers that are present in
the adjacent bone [1,20]. Paradoxically, if this were the
only mechanism driving arthritic joint pain, a clear cor-
relation should appear between joint deterioration/
destruction and joint pain. However, in both trauma
and age-related osteoarthritis, a poor correlation is
noted between the extent of joint destruction and the
frequency and severity of joint pain [3,21,56].
Although these mechanisms certainly contribute to
arthritic joint pain, the present data demonstrate that
the nerve fibers that innervate the joint are not simply
static structures that respond to changes in the joint
and bone but rather can undergo a remarkable reorgani-
zation in terms of altered morphology, increase in the
density of nerve fibers per unit area, and sprouting into
areas of the joint that are normally poorly innervated.
The populations of nerve fibers that are undergoing
sprouting include CGRP+ and NF200+ sensory nerve
fibers that correspond to unmyelinated/thinly myeli-
nated and thinly myelinated sensory nerve fibers, respec-
tively, as well as TH+ postganglionic sympathetic nerve
fibers. Previous human [57-69] and rodent
[23,35,46,70-74] studies have shown that inappropriate
remodeling of sensory and sympathetic nerve fibers can
be associated with skeletal [23,35,46,62,63,68,69,71] and
nonskeletal pain [57,60,64-67,72-74]. As we observed a
similar remodeling of sensory and sympathetic nerve
fibers in geriatric arthritic knee joints, this pathologic
reorganization of nerve fibers would then set in place a
neuroanatomic substrate that could drive movement
and resting arthritic joint pain.
In addition to the robust sprouting of sensory and
sympathetic nerve fibers in the knee joints of the geria-
tric mice that received injections of CFA, we observed
the appearance of neuroma-like structures in the syno-
vium and femoral periosteum. Previous preclinical and
clinical studies have shown that injury to peripheral
nerves due to trauma, amputation, compression, or sur-









































































Figure 3 Histograms showing the changes induced by CFA injection into the geriatric knee joint. Volume of synovium (mm3) (A), density
of PECAM+ blood vessels (B), but not the density of CD68+ macrophages per unit area (C) were increased 4 weeks after initial CFA injection.
Each bar represents the mean ± SEM. *P < 0.05 versus mice that received intraarticular injections of saline as vehicle.
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Figure 4 Sensory nerve fiber sprouting and formation of neuroma-like structures in the painful geriatric arthritic knee joint. Schematic of
a frontal view of a cross-sectioned mouse knee joint (A). The red square illustrates the synovial region from which the confocal images were
obtained. Representative confocal images of calcitonin gene-related peptide (CGRP+), neurofilament 200-kDa (NF200+) sensory nerve fibers (yellow/
orange), and growth-associated protein (GAP43; marker of fibers undergo regeneration, yellow/orange) and DAPI-labeled nuclei (blue) in knee-joint
sections (20 μm thick) of vehicle-injected (B, D, F, H) and CFA-injected (C, E, G, I) mice. In vehicle-injected mice, a low-level, regular pattern of
innervation by CGRP+ and NF200+ fibers is observed in the synovial space of the knee joint. Twenty-eight days after the initial CFA injection, a
significant number of CGRP+, NF200+, and GAP43+ nerve fibers have sprouted and have a disorganized appearance, as compared with vehicle-
injected mice. Note that CGRP+, NF200+, and GAP43+ sprouted nerve fibers are localized in the synovium and are not observed in the meniscus of
the joint. Furthermore, formation of neuroma-like structures occurred in the synovium of the geriatric mice injected with CFA (G).
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[58,59,75,76], which have a morphology similar to the
neuroma-like structures observed in the present study.
In humans, these nonmalignant neuromas frequently
cause chronic and severe pain [58,59,77], produce spon-
taneous ectopic discharges [76,78,79], in part by upregu-
lation of sodium channels [59,80,81], and are largely
refractory to medical treatment [59]. Whether these
neuroma-like structures in the geriatric arthritic knee
joints also show an upregulation of sodium channels
and produce spontaneous discharges is unknown, but
these structures could partially explain the phenomenon
of spontaneous arthritic joint pain (pain at rest), as
movement would not be required for these spontaneous
ectopic and painful discharges to occur.
In addition to the reorganization of nerve fibers in the
knee joints of the geriatric mice that received injections
of CFA, we found a significant increase in the total
number of CD68+ macrophages/monocytes in the syno-
vium (as the inflamed synovium is much larger than the



























































































CGRP+ nerve fibers 
(unmyelinated and lighty myelinated sensory)
GAP-43+ nerve fibers 




NF200+ nerve fibers 
(myelinated sensory)
TH+ nerve fibers 
(postganglionic sympathetic)
Figure 5 Histograms showing an increase in the density of sensory and sympathetic nerve fibers in the geriatric arthritic knee joint.
The length of calcitonin gene-related peptide (CGRP+, A) sensory nerve fibers, neurofilament 200 kDa (NF200+, B) sensory nerve fibers, tyrosine
hydroxylase (TH+, C) postganglionic sympathetic nerve fibers and growth-associated protein-43+ (GAP-43+, D) nerve fibers undergoing sprouting
in the synovium were obtained by manually tracing the nerve fibers in a determined volume of synovium. Bars represent the mean of at least
three mice ± SEM. *P < 0.05 versus mice that received intraarticular injections of saline.
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Figure 6 Intraarticular injection of CFA induces nerve sprouting and formation of neuroma-like structures in the periosteum. (A)
Schematic of the frontal view of a cross-sectioned mouse knee joint illustrating the periosteal region from which the confocal images were
obtained (red square). Representative confocal images of CGRP+ and NF200+ sensory nerve fibers (yellow/orange), TH sympathetic nerve fibers
(yellow/orange), and DAPI labeled nuclei (blue) in 20 μm-thick knee sections from vehicle-injected (B, D, F, H) and CFA-injected (C, E, G, I)
mice. In vehicle-injected mice, a low-level, regular pattern of innervation by CGRP+, NF200+, and TH+ nerve fibers is observed in the synovial
space of the knee joint. Twenty-eight days after the initial CFA injection, a significant number of CGRP+, NF200+, and TH+ nerve fibers have
sprouted and have a disorganized appearance as compared with vehicle-injected mice. Furthermore, a formation of neuroma-like structures by
NF200+ nerve fibers was seen in the femoral periosteum of the geriatric mice injected with CFA (I).
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the density per unit areas of these inflammatory cells.
Although the lack of change in macrophage/monocyte
density in relation to the difference in total numbers of
these cells between the groups is unknown, it is possible
that that age-related loss in the macrophage infiltration
and function may explain this finding [82].
Sprouting of sensory and sympathetic nerve fibers in the
geriatric knee joint
In general, neuroplasticity is thought to decline with age.
For example, a previous study showed that the rate of
axonal regeneration as determined by axonal transport
of radiolabeled proteins after sciatic nerve injury is
slower in 28-month-old rats as compared with 2- and
10-month old rats [27]. In 24-month-old mice, the num-
ber of regenerating myelinated axons in tibial fascicles is
significantly reduced (~50% decrease) compared with 6-
month-old mice after crushing at the sciatic nerve [25].
Additionally, it has been shown that the collateral
sprouting of sensory and sympathetic axons after injury
is 50% less in aged rats as compared with young rats
[24,26].
In contrast to these studies, our results indicate that
sensory and sympathetic nerve fibers that innervate the
knee joints of geriatric mice not only retained the capa-
city to undergo a robust and inappropriate sprouting
but they also formed neuroma-like structures after
inflammation or injury. One potential explanation as to
why the neuronal sprouting of sensory and sympathetic
nerve fibers is so robust in the aged knee joint is that an
age-related maintenance occurs in the synthesis and
release of growth factors from skeletal tissues. In sup-
port of this hypothesis, the expression of different
growth factors, including bone morphogenetic protein-2,
bone morphogenetic protein-7, insulin-like growth fac-
tor-1, leptin, tumor necrosis factor-a, and transforming
growth factor-b are maintained and/or increased in the
intervertebral discs in aged rabbits and humans [83-85].
Additionally, maintenance in the expression and respon-
siveness of receptors expressed by the nerves innervating
the joints may promote the nerve sprouting and neu-
roma formation observed in the present study.
A key unknown is the factor(s) driving the sprouting
and neuroma formation of sensory nerve fibers and ulti-
mately the pain in the painful inflamed joint. Previous
reports exhaustively demonstrated that in both the
developing and adult animal, nerve growth factor can
induce marked sprouting of sensory and sympathetic
nerve fibers (see [86] for review). Furthermore, previous
studies in our laboratory, using a mouse monoclonal
antibody against NGF (anti-NGF), showed that sustained
administration of anti-NGF results in a marked reduc-
tion of sprouting and neuroma-like formation by CGRP
+, TH+, and NF200+ nerve fibers in the tumor-bearing
bone, irrespective of whether the tumor synthesizes
NGF [35,46,71]. These data, together with significant lit-
erature suggesting that macrophages, neutrophils,
endothelial cells, T-lymphocytes, and fibroblasts can all
express significant levels of NGF (see [87] for refer-
ences), suggest that NGF may be a key factor driving
the reorganization of sensory and sympathetic nerve
fibers in inflamed knee joints from geriatric mice.
Conclusions
In this study, CFA-induced inflammation of the geriatric
knee joint resulted in significant pain, robust nerve
sprouting, and formation of neuroma-like structures in
the synovium and periosteum by both sensory (CGRP+
and NF200+) and sympathetic (TH+) nerve fibers. Inter-
estingly, these sprouting nerve fibers were present at a
higher density and had unique morphology that is never
observed in the normal nonpainful geriatric knee joint.
Although robust sprouting and neuroma formation are
clearly present at 28 days after CFA injection, it remains
to be determined when this nerve sprouting and neu-
roma formation first begins.
As sprouting and reorganization of sensory and sym-
pathetic nerve fibers has been observed in other chronic
pain states in both animals and humans [23,35,46,57-71]
and has been correlated with the establishment of a
chronic pain state, the present data suggest that ectopic
sprouting may be involved in the generation and/or
maintenance of arthritic pain in the aged joint. Under-
standing the specific factors that promote the observed
nerve sprouting, defining the contribution that ectopic
nerve sprouting plays in driving arthritic joint pain, and
determining whether this ectopic nerve sprouting is
transitory or permanent in nature may provide mechan-
istic insight and novel pharmacologic targets for more
effective control of age-related joint pain.
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